Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple SclerosisMingjing Chen, Rose Noroozi, Matthew D Smith, et al.
Biomedical Optics Express|February 7, 2015
Automatic segmentation of microcystic macular edema in OCTAndrew Lang, Aaron Carass, Emily K Swingle, et al.
Brain : a Journal of Neurology|March 16, 2021
Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibitionPavan Bhargava, Sol Kim, Arthur A Reyes, et al.
Molecular Neurodegeneration Advances|December 26, 2025
Serum metabolomic-lipidomic signatures track long-term neurological performance in multiple sclerosisRose Noroozi, Hui-Hsin Tsai, Ketian Yu, et al.
Brain, Behavior, & Immunity - Health|June 9, 2025
Machine learning-based prediction of anxiety disorders using blood metabolite and social trait data from the UK BiobankAnnabel Smith, Jack J Miller, Daniel C Anthony, et al.
Metabolites|November 26, 2024
Extraction Methods for Brain Biopsy NMR Metabolomics: Balancing Metabolite Stability and Protein PrecipitationWenzheng Xiong, Florian Zirpel, M Zameel Cader, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 14, 2002
The systemic and local acute phase response following acute brain injuryDavid C Wilcockson, Sandra J Campbell, Daniel C Anthony, et al.
The European Journal of Neuroscience|November 26, 2005
Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatmentAndrew E M Davis, Sandra J Campbell, Panop Wilainam, et al.
Annals of Clinical and Translational Neurology|January 19, 2019
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changesPavan Bhargava, Kathryn C Fitzgerald, Swarajya L V Venkata, et al.
Neurology|January 1, 2016
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosisElias S Sotirchos, Pavan Bhargava, Christopher Eckstein, et al.
Pageof 26